Abstract
The purpose of this chapter is to provide an overview of the most common types of cancer treatment modalities and to describe the role of navigators on the multidisciplinary treatment team during these phases of care. Patients may receive just one phase of treatment, such as surgery, or may be transitioned through various phases of treatment such as surgery, chemotherapy, radiation, and hormonal therapy. Each phase or treatment requires decision-making, and the navigator serves as a patient advocate and patient educator and promotes the patient’s active participation in the treatment decisions that are being made. Navigators also reassess the patient for any barriers to care; these barriers can change depending on the phase of treatment the patient is receiving at any given time. A description of multi-level barriers, and strategies to address those barriers, is provided. Tables are provided for ease of reference. Several case studies are presented to highlight the role of the navigator throughout treatment. Special attention is given to Native American cancer patients, as well as sexual and gender minorities, two populations often ignored in mainstream patient navigation literature.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Willis LA, Reed E, Pratt-Chapman M, Kapp H, Hatcher E, Vaitones V, Collins S, Bires J, Washington E. Development of a framework for patient navigation: delineating roles across navigator types. J Oncol Navig Surviv. 2013;4:20–6.
Morra M, Potts E. Choices. New York: Avon Books; 1994.
www.cancer.org/content/cancer/en/search.html?q=targeted+therapies.
www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet.
www.cancer.gov/about-cancer/treatment/types/hormone-therapy.
www.cancer.gov/about-cancer/treatment/types/hormone-therapy#HTCCSE.
National Cancer Institute. Immunotherapy. 2017. www.cancer.gov/research/areas/treatment/immunotherapy-using-immune-system.
National Cancer Institute. Immunotherapy. 2017. www.cancer.gov/about-cancer/treatment/types/immunotherapy.
Parkinson AJ, Gold BD, Bulkow L, Wainwright RB, Swaminathan B, Khanna B, Peterson KM, Fitzgerald MA. High prevalence of Helicobacter pylori in the Alaska Native Population and Association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol. 2000;7(6):885–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Burhansstipanov, L., Shockney, L.D. (2018). The Role of the Navigator During a Patient’s Cancer Treatment. In: Shockney, L. (eds) Team-Based Oncology Care: The Pivotal Role of Oncology Navigation. Springer, Cham. https://doi.org/10.1007/978-3-319-69038-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-69038-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69037-7
Online ISBN: 978-3-319-69038-4
eBook Packages: MedicineMedicine (R0)